相关实验视频
Updated: May 5, 2026

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
38.0K
转录网络用于脑瘤的介质细胞转化
Maria Stella Carro1, Wei Keat Lim, Mariano Javier Alvarez
1Institute for Cancer Genetics, Columbia University Medical Center, New York, New York 10032, USA.
Nature
|December 25, 2009
概括
两个转录因子,C/EBPbeta和STAT3,在恶性质瘤中驱动介质细胞转化. 它们的激活启动并维持这种侵略性瘤表型,提供潜在的治疗点.
科学领域:
- 系统生物学 系统生物学
- 癌症研究 癌症研究
- 分子瘤学分子瘤学
背景情况:
- 恶性质细胞瘤的攻击性与一个介质细胞表型有关.
- 驱动这种表型的调节网络在很大程度上是未知的.
- 了解这些网络对于开发有针对性的疗法至关重要.
研究的目的:
- 为了确定负责恶性质瘤中中介细胞基因表达的转录调节者.
- 阐明这些调节剂在质瘤发育和进展中的作用.
主要方法:
- 对质瘤特异性监管网络的逆向工程.
- 对转录模块进行公正的审讯.
- 对转录因子表达 (共表达和消除) 的实验操纵.
主要成果:
- 确定了一种特定的转录模块激活介质细胞基因.
- 发现C/EBPbeta和STAT3是中酶体转化的关键协同调节剂.
- 在神经干细胞中,C/EBPbeta和STAT3诱导的介质细胞系的同时表达.
- 消除C/EBPbeta和STAT3降低了间酶体特征和质瘤细胞中的攻击性.
- 高C/EBPbeta和STAT3表达与间细胞分化和人类质瘤的不良预后相关.
结论:
- 一个由C/EBPbeta和STAT3驱动的小调节模块是必要的,并且足以启动和维持癌细胞中介酶体表型.
- 这些发现突出了C/EBPbeta和STAT3作为质瘤攻击性和潜在治疗点的关键驱动因素.
相关概念视频
Master Transcription Regulators
6.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K

